About Capsule
Capsule operates in the pharmacy industry, focusing on improving healthcare delivery through technology. The company provides customized pharmaceutical services to a variety of clients, including doctors, hospitals, insurers, and manufacturers. Capsule's approach involves creating a brand that resonates emotionally with its users while addressing the complexities of the healthcare system. Unlike traditional pharmacies, Capsule emphasizes tailored solutions that enhance efficiency and effectiveness in medication management. The company generates revenue through partnerships and service agreements, and it has attracted significant investment, raising over $500 million to support its growth and impact in the healthcare sector.
Town of Darien, New YorkHeadquarters
2015Year Founded
$554.5MTotal Funding
LATE_VCCompany Stage
Enterprise Software, HealthcareIndustries
501-1,000Employees
Benefits
Child Care & Parental Leave Benefits - Flexible Work Schedule, Generous Parental Leave
Health Insurance & Wellness - Dental Benefits, Disability Insurance, Flexible Spending Account (FSA), Health Insurance Benefits, Vision Benefits
401(K)
Unlimited Vacation Policy
Risks
Competition from telehealth platforms like Teladoc may impact Capsule's market share.
Rapid growth of digital health startups increases competition for investment.
Capsule faces challenges in maintaining differentiation amidst expanding healthcare technology solutions.
Differentiation
Capsule leverages technology to deliver customized outcomes for healthcare stakeholders.
Capsule focuses on emotionally resonant experiences in the complex healthcare system.
Capsule partners with diverse healthcare entities to enhance pharmaceutical service efficiency.
Upsides
Increased telehealth adoption boosts demand for integrated pharmacy solutions like Capsule's.
Rise of personalized medicine aligns with Capsule's tailored pharmaceutical services.
Growing digital health investments highlight market interest in Capsule's solutions.
Funding
Total raised$554.45 M
Latest valuation$1.00 B
StageLATE_VC
$300
$1.00 BSERIES C
8/31/2019$200
$900.00 M$50
$250.00 MSERIES A
4/30/2017$20
$100.00 M